MustGrow Biologics Corp experienced significant insider activity on August 28, 2025, when four key individuals, including directors and senior officers, executed substantial buy orders. These acquisitions represent the most recent transactions recorded for the firm, marking a notable shift in internal positioning compared to historical divestment patterns observed in late 2022.